Bacterial enterotoxin (ET)

Bacterial enterotoxins are a broad class of protein exotoxins produced by pathogenic microorganisms, such as Staphylococcus aureus, Escherichia coli, and Vibrio cholerae, that specifically target the gastrointestinal tract (StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK519509/). These toxins primarily function by altering cellular signaling pathways—most notably through the activation of adenylate or guanylate cyclases—which leads to an imbalance of electrolytes and massive fluid secretion, resulting in watery diarrhea (Wikipedia, https://en.wikipedia.org/wiki/Enterotoxin; PubMed, https://pubmed.ncbi.nlm.nih.gov/24438310/). Certain variants, such as Staphylococcal enterotoxin B (SEB), also act as superantigens that non-specifically cross-link MHC class II molecules with T-cell receptors, triggering a systemic cytokine storm and toxic shock syndrome (PubMed, https://pubmed.ncbi.nlm.nih.gov/22401874/). In drug development, enterotoxins are viewed as targets for neutralization by monoclonal antibodies (antitoxins), such as bezlotoxumab for Clostridium difficile toxins, or sequestration by oral binders like cholestyramine (FDA, https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761046s000lbl.pdf). Because "enterotoxin" refers to a functional category rather than a single molecular entity, therapeutic strategies must be precisely tailored to the specific toxin and bacterial species involved (Nature Reviews Microbiology, https://www.nature.com/articles/nrmicro2232).

Other names

Enterotoxic exotoxinBacterial gut toxinSuperantigen (select types)Gastrointestinal toxinEnteric toxin

Drugs targeting bacterial enterotoxins primarily utilize neutralization or sequestration; monoclonal antibodies (antitoxins) bind to specific epitopes on the toxin to prevent its interaction with host cell receptors, while binding resins sequester toxins within the intestinal lumen to facilitate their excretion (StatPearls, https://www.ncbi.nlm.nih.gov/books/NBK519509/; FDA, https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/761046s000lbl.pdf).